# EDGAR Filing Document

**Accession Number:** 0001792030
**File Stem:** 0001178913-25-003598
**Filing Date:** 2025-10
**Character Count:** 8278
**Document Hash:** 4b340bc25b8243abbef9c279abcaed79
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001178913-25-003598.hdr.sgml**: 20251029

**ACCESSION NUMBER**: 0001178913-25-003598

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251029

**FILED AS OF DATE**: 20251029

**DATE AS OF CHANGE**: 20251029

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IM Cannabis Corp.
- **CENTRAL INDEX KEY:** 0001792030
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40065
- **FILM NUMBER:** 251430261

**BUSINESS ADDRESS:**
- **STREET 1:** KIBBUTZ GLIL YAM
- **CITY:** CENTRAL DISTRICT
- **STATE:** L3
- **ZIP:** 4690500
- **BUSINESS PHONE:** 416-256-4202

**MAIL ADDRESS:**
- **STREET 1:** KIBBUTZ GLIL YAM
- **CITY:** CENTRAL DISTRICT
- **STATE:** L3
- **ZIP:** 4690500

------

**UNITED STATES**<br> **SECURITIES AND EXCHANGE COMMISSION**<br> Washington, D.C. 20549<br>

**Form 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16**<br> **UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of **<u>October 2025 (Report No. 3)</u>**.

Commission File Number: **<u>001-40065</u>**

<br> **<u>IM Cannabis Corp.</u>**<br> (Exact Name of Registrant as Specified in Charter)

<br> **<u>Kibbutz Glil Yam, Central District, Israel 4690500</u>**<br> (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

------

#### CONTENTS
On October 29, 2025, IM Cannabis Corp. (the "**Company**") announced that Mr. Uri Birenberg, the Company's Chief Financial Officer, will be stepping down from his position for personal reasons. Mr. Birenberg is expected to continue serving as Chief Financial Officer until January 5, 2026, or such earlier date as may be determined by the Company. Mr. Birenberg's decision to step down was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.

This Report of Foreign Private Issuer on Form 6-K, excluding the second and third paragraphs of the press release included as Exhibit 99.1 hereto, is incorporated by reference into the Company's Registration Statements on Form F-3 (File No. [333-289571](https://www.sec.gov/Archives/edgar/data/1792030/000117891325002865/zk2533632.htm) and [333-288346](https://www.sec.gov/Archives/edgar/data/1792030/000117891325002247/zk2533384.htm)) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

------

#### EXHIBIT INDEX

---

| | |
|:---|:---|
| **Exhibit No.** |  |
| [99.1](exhibit_99-1.htm) | [Press Release dated October 29, 2025 "IM Cannabis Announces CFO Departure".](exhibit_99-1.htm) |

---

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **IM CANNABIS CORP.** | **IM CANNABIS CORP.** |
|  |  | (Registrant) | (Registrant) |
| Date: | October 29, 2025 | By: | */s/ Oren Shuster* |
|  |  | Name: | Oren Shuster |
|  |  | Title: | Chief Executive Officer and Director |

---

------

## Exhibit 99.1

------

 <u>**Exhibit 99.1**</u>

#### IM Cannabis Announces CFO Departure
Toronto, Ontario and GLIL YAM, Israel, October 29, 2025/CNW/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "**Company**", "**IM Cannabis**", or "**IMC**"), a leading international medical cannabis company with operations in Israel and Germany, today announced that Uri Birenberg, the Company's Chief Financial Officer, will be stepping down from his role for personal reasons. Mr. Birenberg is expected to continue serving as Chief Financial Officer until January 5, 2026, or such earlier date as may be determined by the Company, and will assist in a structured transition process until a successor is appointed.

Oren Shuster, Chief Executive Officer of IMC, said, "On behalf of our entire team, I would like to thank Uri for his commitment and contribution to IMC. Over the past two years, he has been a valued member of our leadership. We wish him every success in his next chapter."

"It has been a great pleasure to serve as the Company's Chief Financial Officer over the past two years," said Uri Birenberg. "I have the highest confidence in the Company and am grateful for the opportunity to work with one of the most dedicated teams in the cannabis industry".

#### About IM Cannabis Corp.

The IMC ecosystem operates in Israel through its subsidiaries, which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

#### Disclaimer for Forward-Looking Statements
This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, "forward-looking statements"). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect", "likely" and "intend" and statements that an event or result "may", "will", "should", "could" or "might" occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to the Company's search for a new Chief Financial Officer.

------

Forward-looking information in this press release is based on certain assumptions and expected future events, namely: the Company having the ability to complete its search for a new Chief Financial Officer and the expected timing of such appointment.

Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include: the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company's inability to continue to meet the listing requirements of the Nasdaq Capital Market; any unexpected failure to maintain in good standing or renew its licenses; and the Company's inability to complete its search for a new Chief Financial Officer and the and the expected timing of such appointment.

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

#### Company Contacts:
Anna Taranko, Director Investor & Public Relations

IM Cannabis Corp.

+49 157 80554338

a.taranko@imcannabis.de

Oren Shuster, CEO

IM Cannabis Corp.

info@imcannabis.com

------